Extension of the phenotypic spectrum of BMP1-related disorders through a novel homozygous variant identified in a foetus with intrauterine growth retardation
This study reports the first prenatal case of a homozygous BMP1 variant causing severe intrauterine growth restriction and multiple malformations, thereby expanding the phenotypic spectrum of BMP1-related disorders beyond postnatal osteogenesis imperfecta and highlighting the gene's critical role in early human development.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The human body is built on a framework of connective tissues, with bones serving as the most rigid and visible part of this structure. These bones rely heavily on type I collagen, a tough, fibrous protein that acts as the primary scaffolding for the skeleton, skin, and tendons. However, collagen does not appear in its final, strong form immediately. It is secreted by cells as a longer, looser precursor called procollagen. To become the sturdy material needed for life, this precursor must be trimmed at its ends by specific molecular scissors. One of the most critical of these scissors is an enzyme called BMP1. Without this enzyme performing its precise cutting job, the collagen fibers cannot assemble correctly, leading to fragile bones and a host of other developmental issues. While doctors have long known that defects in the genes responsible for making collagen itself cause brittle bone disease, the role of the enzymes that process this collagen has been less understood, particularly regarding how their absence affects a baby before birth.
A team of researchers recently uncovered a severe case that expands our understanding of what happens when the BMP1 enzyme is missing or broken. They examined a fetus at twenty-three weeks of pregnancy that was showing signs of severe growth restriction and multiple physical abnormalities. Standard ultrasound scans revealed that the baby was significantly smaller than expected, had clubfeet, and showed unusual features in the skull and brain. The medical team performed a detailed genetic analysis on cells taken from the amniotic fluid surrounding the fetus. They discovered that the fetus had inherited two identical copies of a specific error in the BMP1 gene, one from each parent. This genetic mistake was located in a region of the gene that acts as the instruction manual for the enzyme's cutting mechanism.
The researchers found that this single genetic error had a double impact on the body's ability to function. First, the error disrupted the way the cell reads the genetic instructions, causing it to skip a crucial section of the code. This skipping led to a broken version of the enzyme that could not be made in sufficient quantities. Second, the small amount of enzyme that was still produced carried a structural flaw that made it significantly less effective at its job. In laboratory tests, the faulty enzyme struggled to cut the collagen precursors and other important proteins it normally processes. It was only about half as efficient as the healthy version, meaning the body could not clear the way for strong bone formation or proper tissue development.
This case is unique because it is the first time such a severe defect in the BMP1 gene has been identified in a fetus before birth. Previously, similar genetic errors were only known to cause problems in children or adults, typically resulting in brittle bones and fractures later in life. In this instance, the combination of having no working enzyme and a broken one led to a much more complex and severe outcome. The fetus exhibited not just bone issues, but also significant problems with brain development and the shape of the skull. The researchers suggest that the enzyme's role goes beyond just cutting collagen; it is also essential for releasing other signals that guide how the body forms its shape during early development. When this enzyme fails, the entire process of building the body's architecture is thrown off balance.
The discovery highlights that the BMP1 gene should be considered when doctors are investigating severe, unexplained abnormalities in a fetus. By identifying this specific genetic cause, the study broadens the list of conditions that can be diagnosed before birth. It also underscores the importance of understanding how a single genetic change can have multiple effects, disrupting both the amount of protein made and its ability to work. While the researchers could not determine the exact cause of the pregnancy loss, their work provides a clear explanation for the severe physical changes observed. It confirms that the BMP1 enzyme is a vital player not just in making bones strong, but in ensuring the complex, coordinated development of the human body from its earliest stages.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.